Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia

Xue Wang(University of Pittsburgh Medical Center), Xiaohui Wang(Chinese Academy of Sciences)
Frontiers in Immunology
August 10, 2022
Cited by 19


Related Papers